Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Prospective Observational Immunogenicity Trial of Gardasil-9 HPV Vaccine in People Living With Adequately Managed HIV

NCT05266898 is registered in ClinicalTrials.gov with Louisiana State University Health Sciences Center in New Orleans as lead sponsor.

NCT NCT05266898
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05266898 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Prospective Observational Immunogenicity Trial of Gardasil-9 HPV Vaccine in People Living With Adequately Managed HIV
Lead sponsor
Louisiana State University Health Sciences Center in New Orleans
Phase
Phase 4
Overall status
Recruiting
Start date
November 30, 2022
Completion date
June 30, 2026
Enrollment
250 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

anal intraepithelial neoplasia, cervical intraepithelial neoplasia, human immunodeficiency virus, oral cavity infection, papillomavirus infection, papillomavirus vaccines, serology